As the year comes to an end and we reflect on our firm’s activities over the past 12 months, we are filled with gratitude for..
Meeting amazing companies and founders at 11 industry events JPM, CES, HLTH, ViVE, Black Hat, RSA, BIO, Nvidia GTC, GCV, TIDE, and the LBS Healthcare Conference.
Welcoming 10 new companies to our portfolio family including AuthMind, Bifrost, Outpace, Conduce, Violet, Closed Loop Medicine, and several exciting undisclosed investments.
Our portfolio developing and using 9 breakthrough technologies - edge sensing (Empatica), computer vision (Optellum), automation (Conceivable), generative AI (Hyro and Blaze.tech), TCR mapping, graph database technology (TigerGraph), protein design (Outpace), PCR, and gene synthesis
Addressing 8 major health areas and chronic conditions - obesity, infertility, epilepsy, migraines, fallopian cancer, ovarian cancer, lung cancer, heart disease
Thank you of course to our
7 Advisory members - Ateev Mehrotra, Seema Parmar, Lilly Alexander, Jason Pinto, Jodi Hubler, Jake Seid, Brandon Wang
6 Corporate partners
5 BOV Fellows - Brendan Johnson, Vanessa Stephens, Sandy Uwimana, Renee Lamb, Azan Zahir Virji
4 Interns - Maxime Lasseel, Brendan Johnson, Rhydian Harris, Deepesh Ondhia
3 Venture partners - Joseph Jeong, Carina Tyrrell, Eve Castel
2 Executive advisors - Simon Segars and Tamra Lair
So that we could all come together for our 1st ever Brilliant Tomorrows Forum!
Comments